相似文献
1
Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
Br J Pharmacol. 1971 Dec;43(4):856-64. doi: 10.1111/j.1476-5381.1971.tb07222.x.
2
The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
Br J Pharmacol. 1974 Sep;52(1):19-26. doi: 10.1111/j.1476-5381.1974.tb09682.x.
3
The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine.
J Neurochem. 1972 Oct;19(10):2409-22. doi: 10.1111/j.1471-4159.1972.tb01295.x.
4
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
J Neurochem. 1971 Jun;18(6):1053-66. doi: 10.1111/j.1471-4159.1971.tb12034.x.
5
The effect of inhibitors of protein synthesis to inhibit brain protein synthesis and prevent the hyperactivity and hyperpyrexia in rats produced by inhibition of monoamine oxidase and the administration of L-tryptophan or 5-methoxy-NN-dimethyltryptamine.
Biochem J. 1972 Apr;127(2):7P. doi: 10.1042/bj1270007pc.
6
Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
Br J Pharmacol. 1977 Feb;59(2):367-71. doi: 10.1111/j.1476-5381.1977.tb07501.x.
7
The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
Br J Pharmacol. 1978 Oct;64(2):201-9. doi: 10.1111/j.1476-5381.1978.tb17290.x.
8
Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Br J Pharmacol. 1975 Nov;55(3):415-22. doi: 10.1111/j.1476-5381.1975.tb06946.x.
9
A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
Br J Pharmacol. 1981 Jul;73(3):703-19. doi: 10.1111/j.1476-5381.1981.tb16806.x.
10
Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
J Neural Transm. 1976;39(1-2):103-12. doi: 10.1007/BF01248769.
引用本文的文献
1
5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?
Psychopharmacology (Berl). 2023 Dec 11. doi: 10.1007/s00213-023-06517-1.
2
A narrative synthesis of research with 5-MeO-DMT.
J Psychopharmacol. 2022 Mar;36(3):273-294. doi: 10.1177/02698811211050543. Epub 2021 Oct 19.
3
Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
Pharmacol Biochem Behav. 2016 Apr;143:1-10. doi: 10.1016/j.pbb.2016.01.005. Epub 2016 Jan 15.
4
Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.
Eur J Pharmacol. 2008 Jul 7;588(2-3):198-206. doi: 10.1016/j.ejphar.2008.04.004. Epub 2008 Apr 8.
5
Neuropharmacology of 5-hydroxytryptamine.
Br J Pharmacol. 2006 Jan;147 Suppl 1(Suppl 1):S145-52. doi: 10.1038/sj.bjp.0706427.
6
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Br J Pharmacol. 2002 Jan;135(1):170-80. doi: 10.1038/sj.bjp.0704442.
7
Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.
Br J Pharmacol. 1996 Feb;117(4):750-6. doi: 10.1111/j.1476-5381.1996.tb15254.x.
8
An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT.
Psychopharmacology (Berl). 1993;112(1):55-63. doi: 10.1007/BF02247363.
9
Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").
Psychopharmacology (Berl). 1995 Jun;119(3):247-60. doi: 10.1007/BF02246288.
10
The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.
Naunyn Schmiedebergs Arch Pharmacol. 1980 Mar;311(2):185-92. doi: 10.1007/BF00510258.
本文引用的文献
1
Aromatic L-amino acid decarboxylase.
J Biol Chem. 1962 Jan;237:89-93.
2
Behavioral effects and brain amine content in rats.
Arch Int Pharmacodyn Ther. 1961 Nov 1;134:89-99.
3
[The effect of chlorpromazine on catecholamine and 5-hydroxytryptamine metabolism in the rat brain].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;239:507-19.
4
The biosynthesis of 5-hydroxytryptamine in brain.
Biochem J. 1967 Oct;105(1):351-60. doi: 10.1042/bj1050351.
5
The determination of tryptophan in plasma, liver, and urine.
J Lab Clin Med. 1967 Jan;69(1):160-9.
6
Some studies of the effects of chlorpromazine, reserpine and dihydroxyphenylalanine on the concentrations of homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in ventricular cerebrospinal fluid of the dog using the technique of serial sampling of the cerebrospinal fluid.
Br J Pharmacol Chemother. 1968 Jul;33(3):457-71. doi: 10.1111/j.1476-5381.1968.tb00494.x.
7
Fate and metabolism of some hallucinogenic indolealkylamines.
Adv Pharmacol (1962). 1968;6(Pt B):213-29. doi: 10.1016/s1054-3589(08)60320-8.
8
A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine AND SEROTONIN IN A SINGLE BRAIN SAMPLE.
Anal Biochem. 1968 May;23(2):196-206. doi: 10.1016/0003-2697(68)90351-5.
9
Phenelzine poisoning responding to phenothiazine.
Med J Aust. 1969 Dec 13;2(24):1214-5.
10
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
J Neurochem. 1971 Jun;18(6):1053-66. doi: 10.1111/j.1471-4159.1971.tb12034.x.
Zotero 插件